Tinubu's sons, Seyi and Yinka, and their associates have donated relief materials to victims of the flood disaster in ...

Two of President Bola Tinubu’s sons, Seyi and Yinka, and their associates at the weekend donated relief materials, including ...

For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced risks for ...

A Cleveland Clinic research team has published the first study assessing the independent real-world impacts of weight loss ...

In response to the recent devastating floods in Maiduguri, Borno State, two of President Bola Tinubu’s children, Seyi Tinubu and ...

Creating a novel drug has always been a risky endeavor for biopharmaceutical companies. Developers and investors face ...

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...

In a report released today, Jo Walton from UBS maintained a Hold rating on Novo Nordisk (0QIU – Research Report), with a price target of ...

In 1996, the Food and Drug Administration approved the labeling for metformin (dimethylbiguanide), the only biguanide currently available in the United States. Phenformin, the other previously ...

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...

Current INSTI vs protease inhibitor or NNRTI use is linked to an increased risk for diabetes, which is slightly attenuated when adjusted for changes in BMI.